Madrigal Pharmaceuticals (MDGL) had the highest return in 2022 by a US stock in the Nasdaq Composite (IXIC) with a market cap of $10B+, returning 238.1%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Madrigal Pharmaceuticals (MDGL) | 2022 | 238.09% |
Constellation Energy (CEG) | 2022 | 128.92% |
Super Micro Computer (SMCI) | 2022 | 84.04% |
APA (APA) | 2022 | 75.2% |
First Solar (FSLR) | 2022 | 70.2% |
Summit Therapeutics (SMMT) | 2022 | 64.03% |
Expand Energy (EXE) | 2022 | 61.42% |
Viper Energy Ut (VNOM) | 2022 | 60.71% |
Steel Dynamics (STLD) | 2022 | 59.48% |
Halozyme Therapeutics (HALO) | 2022 | 42.96% |
Arch Capital (ACGL) | 2022 | 41.08% |
Trip Group Ltd ADR (TCOM) | 2022 | 40.24% |
PDD (PDD) | 2022 | 39.76% |
Neurocrine Biosciences (NBIX) | 2022 | 39.05% |
Alnylam Pharmaceuticals (ALNY) | 2022 | 38.93% |
Plains All American Pipeline (PAA) | 2022 | 35.93% |
Diamondback Energy (FANG) | 2022 | 35.68% |
LPL Financial (LPLA) | 2022 | 35.22% |
Vertex Pharmaceuticals (VRTX) | 2022 | 32.24% |
Erie Indemnity (ERIE) | 2022 | 32% |
United Therapeutics (UTHR) | 2022 | 29% |
Baker Hughes (BKR) | 2022 | 25.75% |
Gilead Sciences (GILD) | 2022 | 24.21% |
Jazz Pharmaceuticals (JAZZ) | 2022 | 24.19% |
Sterling Infrastructure (STRL) | 2022 | 23.54% |